ES2067939T3 - Sistema de distribucion de un medicamento iontoforetico con un perfil de reparto de dos etapas. - Google Patents

Sistema de distribucion de un medicamento iontoforetico con un perfil de reparto de dos etapas.

Info

Publication number
ES2067939T3
ES2067939T3 ES91911198T ES91911198T ES2067939T3 ES 2067939 T3 ES2067939 T3 ES 2067939T3 ES 91911198 T ES91911198 T ES 91911198T ES 91911198 T ES91911198 T ES 91911198T ES 2067939 T3 ES2067939 T3 ES 2067939T3
Authority
ES
Spain
Prior art keywords
iontophoretic
level
current
agent
interval
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91911198T
Other languages
English (en)
Inventor
Paul D Sorenson
John D Bradzinski
Gary A Lattin
Larry A Mcnichols
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alza Corp
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27054046&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2067939(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Alza Corp filed Critical Alza Corp
Application granted granted Critical
Publication of ES2067939T3 publication Critical patent/ES2067939T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/02—Details
    • A61N1/04—Electrodes
    • A61N1/0404—Electrodes for external use
    • A61N1/0408—Use-related aspects
    • A61N1/0428—Specially adapted for iontophoresis, e.g. AC, DC or including drug reservoirs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/20—Applying electric currents by contact electrodes continuous direct currents
    • A61N1/30—Apparatus for iontophoresis, i.e. transfer of media in ionic state by an electromotoric force into the body, or cataphoresis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/325—Applying electric currents by contact electrodes alternating or intermittent currents for iontophoresis, i.e. transfer of media in ionic state by an electromotoric force into the body

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Radiology & Medical Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Electrotherapy Devices (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • External Artificial Organs (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)

Abstract

SE PRESENTA UN SISTEMA IONTOFORETICO DE DOS ETAPAS PARA EL SUMINISTRO DE UNA DROGA EN EL QUE LA CORRIENTE IONTOFORETICA SE SUMINISTRA EN UN PRIMER NIVEL (IH) DURANTE UN PREDETERMINADO INTERVALO DE TIEMPO (T2) PARA INTRODUCIR RAPIDAMENTE UN AGENTE TERAPEUTICO EN EL INTERIOR DE LA CORRIENTE SANGUINEA Y POSTERIORMENTE SE REDUCE HASTA UN SEGUNDO NIVEL INFERIOR (IL) PARA MANTENER UN NIVEL DESEADO DEL AGENTE EN LA SANGRE. EN UNA CONFORMACION EL INTERVALO INICIAL SE MANTIENE DURANTE UN TIEMPO SUFICIENTE PARA SUMINISTRAR UNA DOSIS MAXIMA, DESPUES DE LO CUAL LA CORRIENTE SE CORTA PARA PERMITIR QUE LA CONCENTRACION DEL AGENTE SE ESTABILICE EN LA CORRIENTE SANGUINEA, DESPUES DE LO CUAL SE INICIA UNA CORRIENTE IONTOFORETICA A UN NIVEL DE MANTENIMIENTO. EN OTRA CONFORMACION EL PACIENTE PUEDE INICIAR DE FORMA SELECTIVA UN BREVE INTERVALO DE UN NIVEL DE CORRIENTE IONTOFORETICA INCREMENTADO PARA OBTENER UN BREVE INTERVALO DE DOSIS INCREMENTADA.
ES91911198T 1990-03-30 1991-03-22 Sistema de distribucion de un medicamento iontoforetico con un perfil de reparto de dos etapas. Expired - Lifetime ES2067939T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US50217690A 1990-03-30 1990-03-30
US07/671,306 US5207752A (en) 1990-03-30 1991-03-21 Iontophoretic drug delivery system with two-stage delivery profile

Publications (1)

Publication Number Publication Date
ES2067939T3 true ES2067939T3 (es) 1995-04-01

Family

ID=27054046

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91911198T Expired - Lifetime ES2067939T3 (es) 1990-03-30 1991-03-22 Sistema de distribucion de un medicamento iontoforetico con un perfil de reparto de dos etapas.

Country Status (14)

Country Link
US (1) US5207752A (es)
EP (1) EP0522092B1 (es)
JP (1) JP3181289B2 (es)
KR (1) KR0169084B1 (es)
AT (1) ATE114118T1 (es)
AU (1) AU638581B2 (es)
CA (1) CA2079316C (es)
DE (1) DE69105202T2 (es)
DK (1) DK0522092T3 (es)
ES (1) ES2067939T3 (es)
FI (1) FI110066B (es)
GR (1) GR3015116T3 (es)
NO (1) NO308025B1 (es)
WO (1) WO1991015258A1 (es)

Families Citing this family (84)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3424753B2 (ja) * 1991-12-03 2003-07-07 アルザ コーポレーション イオン導入有効剤投与系
US5505715A (en) * 1994-02-25 1996-04-09 Bristol-Myers Squibb Company Iontophoretic transdermal delivery of deoxyspergualin compounds
US7027859B1 (en) 1994-09-26 2006-04-11 Alza Corporation Electrotransport delivery device having improved safety and reduced abuse potential
US5697896A (en) * 1994-12-08 1997-12-16 Alza Corporation Electrotransport delivery device
US5700481A (en) * 1995-03-17 1997-12-23 Takeda Chemical Industries, Ltd. Transdermal drug delivery process
WO1996031251A1 (de) * 1995-04-07 1996-10-10 Novartis Ag Iontophoretisches transdermales system zum verabreichen von mindestens zwei substanzen
IE960312A1 (en) * 1995-06-02 1996-12-11 Alza Corp An electrotransport delivery device with voltage boosting¹circuit
US5983130A (en) * 1995-06-07 1999-11-09 Alza Corporation Electrotransport agent delivery method and apparatus
AU710793B2 (en) * 1995-06-07 1999-09-30 Alza Corporation Electrotransport agent delivery method and apparatus
WO1997014473A1 (en) * 1995-10-18 1997-04-24 Novartis Ag Thermopile powered transdermal drug delivery device
US6718201B1 (en) * 1996-06-07 2004-04-06 Alza Corporation Electrotransport agent delivery method and apparatus
WO1997048444A1 (en) * 1996-06-19 1997-12-24 Becton Dickinson And Company Iontophoretic delivery of cell adhesion inhibitors
US5857994A (en) * 1996-10-01 1999-01-12 Becton, Dickinson And Company Awakenable iontophoretic/delivery device for reducing electrical sensation upon application thereof
FR2766093B1 (fr) * 1997-07-15 1999-09-03 Lhd Lab Hygiene Dietetique Procede de commande d'un dispositif d'administration transdermique de medicament sous champ electrique
CA2314929C (en) 1997-12-16 2008-09-02 Alza Corporation Regulator with artificial load to maintain regulated delivery
WO1999030775A1 (en) 1997-12-17 1999-06-24 Alza Corporation Iontophoresis with programmed adjustment of electric current
CA2305634C (en) 1998-01-30 2006-01-03 Novo Nordisk A/S An injection syringe
IL144728A0 (en) 1999-02-10 2002-06-30 Gmp Drug Delivery Inc Iontophoresis, electroporation and combination patches for local drug delivery
US6471675B1 (en) 1999-04-30 2002-10-29 Medtronic, Inc. Passive flow control devices for implantable pumps
TW453884B (en) 1999-09-16 2001-09-11 Novo Nordisk As Dose setting limiter
US6663602B2 (en) 2000-06-16 2003-12-16 Novo Nordisk A/S Injection device
US20020197235A1 (en) 2000-11-03 2002-12-26 Moran Stanford Mark Method for short-term and long-term drug dosimetry
DE60237721D1 (de) * 2001-11-09 2010-10-28 Intarcia Therapeutics Inc Kombinationstherapie mit omega-interferon zur behandlung von hepatitis c virus oder gelbfieber virus infektionen
US7731947B2 (en) 2003-11-17 2010-06-08 Intarcia Therapeutics, Inc. Composition and dosage form comprising an interferon particle formulation and suspending vehicle
GB0304822D0 (en) 2003-03-03 2003-04-09 Dca Internat Ltd Improvements in and relating to a pen-type injector
EP2210634A1 (en) * 2009-01-22 2010-07-28 Sanofi-Aventis Deutschland GmbH Drug delivery device dose setting mechanism
GB0308267D0 (en) * 2003-04-10 2003-05-14 Dca Design Int Ltd Improvements in and relating to a pen-type injector
US7220778B2 (en) * 2003-04-15 2007-05-22 The General Hospital Corporation Methods and devices for epithelial protection during photodynamic therapy
US7596407B2 (en) * 2004-03-26 2009-09-29 Solvay Pharmaceuticals, B.V. Transdermal iontophoretic delivery of piperazinyl-2(3H)-benzoxazolone compounds
EP1595542A1 (en) * 2004-03-26 2005-11-16 Solvay Pharmaceuticals B.V. Transdermal iontophoretic delivery of piperazinyl-2(3H)-benzoxazolone compounds
DE602005016952D1 (de) 2004-10-21 2009-11-12 Novo Nordisk As Wählmechanismus für einen drehstift
US11246913B2 (en) 2005-02-03 2022-02-15 Intarcia Therapeutics, Inc. Suspension formulation comprising an insulinotropic peptide
WO2006083761A2 (en) 2005-02-03 2006-08-10 Alza Corporation Solvent/polymer solutions as suspension vehicles
EP1855744A1 (en) * 2005-02-28 2007-11-21 Novo Nordisk A/S A dose setting mechanism for an injection device
US7856263B2 (en) * 2005-04-22 2010-12-21 Travanti Pharma Inc. Transdermal systems for the delivery of therapeutic agents including granisetron using iontophoresis
EP1877121B1 (en) * 2005-04-24 2015-09-23 Novo Nordisk A/S Injection device
EP1931416A2 (en) * 2005-09-30 2008-06-18 Tti Ellebeau, Inc. Iontophoresis method and apparatus for systemic delivery of active agents
WO2007046103A2 (en) * 2005-10-19 2007-04-26 Perf-Action Technologies Ltd. System for iontophoretic transdermal delivery of polymeric agents and methods of use thereof
EP1996260B1 (en) 2006-03-10 2015-09-23 Novo Nordisk A/S An injection device having a gearing arrangement
US8298194B2 (en) 2006-03-10 2012-10-30 Novo Nordisk A/S Injection device and a method of changing a cartridge in the device
AU2012261753B2 (en) * 2006-04-13 2015-03-05 Teva Pharmaceuticals International Gmbh Transdermal methods and systems for the delivery of anti-migraine compounds
CN101472644B (zh) * 2006-04-13 2014-04-23 纽帕特公司 递送抗偏头痛化合物的透皮方法和系统
EP2019701B1 (en) * 2006-05-16 2010-02-24 Novo Nordisk A/S A gearing mechanism for an injection device
US7954624B2 (en) * 2006-05-16 2011-06-07 Rorze Corporation Shuttle type conveying device, microplate feeding and collecting device, pickup device for microplate, cassette for microplate, and shelf for containing microplate
WO2007134954A1 (en) 2006-05-18 2007-11-29 Novo Nordisk A/S An injection device with mode locking means
ES2351527T3 (es) 2006-05-30 2011-02-07 Intarcia Therapeutics, Inc Modulador de flujo en dos piezas con conducto interno para un sistema osmótico de administración.
EP2359808B1 (en) 2006-08-09 2013-05-22 Intarcia Therapeutics, Inc Osmotic delivery systems and piston assemblies
US8728059B2 (en) * 2006-09-29 2014-05-20 Covidien Lp System and method for assuring validity of monitoring parameter in combination with a therapeutic device
DE602008002896D1 (de) 2007-02-05 2010-11-18 Novo Nordisk As Injektionsknopf
AU2008231897B2 (en) 2007-03-23 2012-11-29 Novo Nordisk A/S An injection device comprising a locking nut
EP2157967B1 (en) 2007-04-23 2013-01-16 Intarcia Therapeutics, Inc Suspension formulations of insulinotropic peptides and uses thereof
US8197844B2 (en) 2007-06-08 2012-06-12 Activatek, Inc. Active electrode for transdermal medicament administration
EP2644228A1 (en) * 2007-06-27 2013-10-02 The General Hospital Corporation Method and apparatus for optical inhibition of photodynamic therapy
US20090043244A1 (en) * 2007-08-08 2009-02-12 Inan Omer T Electrotransport Drug Delivery Device Adaptable to Skin Resistance Change
US8862223B2 (en) 2008-01-18 2014-10-14 Activatek, Inc. Active transdermal medicament patch and circuit board for same
CA2726861C (en) 2008-02-13 2014-05-27 Intarcia Therapeutics, Inc. Devices, formulations, and methods for delivery of multiple beneficial agents
US20090259176A1 (en) * 2008-04-09 2009-10-15 Los Gatos Research, Inc. Transdermal patch system
US20090312689A1 (en) * 2008-06-05 2009-12-17 Alza Corporation Adjustable Current Electrotransport Fentanyl Delivery Device
US8155737B2 (en) 2008-06-19 2012-04-10 Nupathe, Inc. Pharmacokinetics of iontophoretic sumatriptan administration
US8366600B2 (en) * 2008-06-19 2013-02-05 Nupathe Inc. Polyamine enhanced formulations for triptan compound iontophoresis
NZ593928A (en) * 2008-12-30 2014-03-28 Nupathe Inc Electronic control of drug delivery system
US8190252B2 (en) 2009-02-12 2012-05-29 Incube Labs, Llc Iontophoretic system for transdermal delivery of active agents for therapeutic and medicinal purposes
US8961492B2 (en) 2009-02-12 2015-02-24 Incube Labs, Llc System and method for controlling the iontophoretic delivery of therapeutic agents based on user inhalation
US8903485B2 (en) * 2009-08-06 2014-12-02 Incube Labs, Llc Patch and patch assembly for iontophoretic transdermal delivery of active agents for therapeutic and medicinal purposes
CN105748401A (zh) * 2009-08-10 2016-07-13 泰华制药国际有限公司 用离子电渗疗法治疗恶心和偏头痛的方法
EP3323423B1 (en) 2009-09-28 2020-06-17 Intarcia Therapeutics, Inc Rapid establishment and/or termination of substantial steady-state drug delivery
WO2011046927A1 (en) * 2009-10-13 2011-04-21 Nupathe,Inc. Transdermal methods and systems for the delivery of rizatriptan
US8685038B2 (en) 2009-12-07 2014-04-01 Incube Labs, Llc Iontophoretic apparatus and method for marking of the skin
US8986279B2 (en) 2010-02-10 2015-03-24 Incube Labs, Llc Methods and architecture for power optimization of iontophoretic transdermal drug delivery
US20120208755A1 (en) 2011-02-16 2012-08-16 Intarcia Therapeutics, Inc. Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
CN106955415B (zh) 2011-03-24 2019-06-18 因卡伯实验室有限责任公司 用于治疗剂的两阶段经皮离子电渗递送的系统及方法
US8428708B1 (en) * 2012-05-21 2013-04-23 Incline Therapeutics, Inc. Self-test for analgesic product
US8428709B1 (en) 2012-06-11 2013-04-23 Incline Therapeutics, Inc. Current control for electrotransport drug delivery
WO2012154704A2 (en) 2011-05-06 2012-11-15 Incube Labs, Llc System and method for biphasic transdermal iontophoretic delivery of therapeutic agents for the control of addictive cravings
US9533106B2 (en) 2011-12-29 2017-01-03 Novo Nordisk A/S Torsion-spring based wind-up auto injector pen with dial-up/dial-down mechanism
US9889085B1 (en) 2014-09-30 2018-02-13 Intarcia Therapeutics, Inc. Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c
MA44390A (fr) 2015-06-03 2019-01-23 Intarcia Therapeutics Inc Systèmes de mise en place et de retrait d'implant
SG11201810102SA (en) 2016-05-16 2018-12-28 Intarcia Therapeutics Inc Glucagon-receptor selective polypeptides and methods of use thereof
USD860451S1 (en) 2016-06-02 2019-09-17 Intarcia Therapeutics, Inc. Implant removal tool
USD840030S1 (en) 2016-06-02 2019-02-05 Intarcia Therapeutics, Inc. Implant placement guide
CN110225762A (zh) 2017-01-03 2019-09-10 因塔西亚制药公司 包括glp-1受体激动剂的连续施用和药物的共同施用的方法
WO2019038412A1 (en) 2017-08-24 2019-02-28 Novo Nordisk A/S GLP-1 COMPOSITIONS AND USES THEREOF
USD933219S1 (en) 2018-07-13 2021-10-12 Intarcia Therapeutics, Inc. Implant removal tool and assembly
AU2021207313A1 (en) 2020-02-18 2022-07-28 Novo Nordisk A/S Pharmaceutical formulations

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3163166A (en) * 1961-04-28 1964-12-29 Colgate Palmolive Co Iontophoresis apparatus
US3618601A (en) * 1969-10-16 1971-11-09 Thatcher W Richardson Iontophoresis unit
US3677268A (en) * 1969-11-28 1972-07-18 Sherwood Medical Ind Inc Iontophoresis electrode
US3794910A (en) * 1971-07-26 1974-02-26 Sherwood Medical Ind Inc Iontophoresis and conductivity analysis circuit
DE2339648C3 (de) * 1973-08-04 1979-09-13 Trebbin, Peter, 8833 Eichstaett Anästhesiegerät zur Behandlung der Zähne
US4141359A (en) * 1976-08-16 1979-02-27 University Of Utah Epidermal iontophoresis device
US4211222A (en) * 1976-08-25 1980-07-08 Robert Tapper Iontophoretic burn-protection method
JPS5347192A (en) * 1976-10-13 1978-04-27 Matsushita Electric Ind Co Ltd Device for introducing fluorine ion to tooth
US4325367A (en) * 1977-06-13 1982-04-20 Robert Tapper Iontophoretic treatment apparatus
US4177817A (en) * 1978-02-01 1979-12-11 C. R. Bard, Inc. Dual terminal transcutaneous electrode
US4215696A (en) * 1978-03-20 1980-08-05 Graphic Controls Corporation Biomedical electrode with pressurized skin contact
US4209020A (en) * 1978-09-19 1980-06-24 Nielsen R Frederick Electrode assembly
US4301794A (en) * 1978-10-18 1981-11-24 Robert Tapper Method for iontophoretic treatment
US4340047A (en) * 1978-10-18 1982-07-20 Robert Tapper Iontophoretic treatment apparatus
US4292968A (en) * 1979-11-26 1981-10-06 Sybron Corporation Electric supply for ion therapy
AU546785B2 (en) * 1980-07-23 1985-09-19 Commonwealth Of Australia, The Open-loop controlled infusion of diabetics
JPS5810066A (ja) * 1981-07-10 1983-01-20 株式会社アドバンス イオントフオレ−ゼ用プラスタ−構造体
US4450844A (en) * 1981-11-23 1984-05-29 Hill Top Research, Inc. Patch system for use on the skin
US4619252A (en) * 1983-04-15 1986-10-28 Ibbott Jack Kenneth Therapeutic method and therapeutic means using a sheetlike battery
US4557723A (en) * 1983-08-18 1985-12-10 Drug Delivery Systems Inc. Applicator for the non-invasive transcutaneous delivery of medicament
US4622031A (en) * 1983-08-18 1986-11-11 Drug Delivery Systems Inc. Indicator for electrophoretic transcutaneous drug delivery device
US4731926A (en) * 1985-02-19 1988-03-22 Drug Delivery Systems Inc. Method of manufacturing disposable and/or replenishable transdermal drug applicators
US4808152A (en) * 1983-08-18 1989-02-28 Drug Delivery Systems Inc. System and method for controlling rate of electrokinetic delivery of a drug
US4640689A (en) * 1983-08-18 1987-02-03 Drug Delivery Systems Inc. Transdermal drug applicator and electrodes therefor
US4708716A (en) * 1983-08-18 1987-11-24 Drug Delivery Systems Inc. Transdermal drug applicator
US4883457A (en) * 1983-08-18 1989-11-28 Drug Delivery Systems Inc. Disposable and/or replenishable transdermal drug applicators and methods of manufacturing same
US4851229A (en) * 1983-12-01 1989-07-25 Alza Corporation Composition comprising a therapeutic agent and a modulating agent
KR880001759B1 (ko) * 1985-06-10 1988-09-12 드럭 딜리버리 시스템스 인코오퍼레이티드 동전학적(動電學的) 의약투여 속도를 제어하는 시스템 및 방법
US4698062A (en) * 1985-10-30 1987-10-06 Alza Corporation Medical device for pulsatile transdermal delivery of biologically active agents
US4725263A (en) * 1986-07-31 1988-02-16 Medtronic, Inc. Programmable constant current source transdermal drug delivery system
US4822334A (en) * 1986-12-04 1989-04-18 Robert Tapper Electrical dosimetry control system
US4731049A (en) * 1987-01-30 1988-03-15 Ionics, Incorporated Cell for electrically controlled transdermal drug delivery
JPH02500339A (ja) * 1987-05-15 1990-02-08 ニューマン，マーティン・エッチ イオン浸透薬剤供給装置
US4865582A (en) * 1987-06-05 1989-09-12 Drug Delivery Systems Inc. Disposable transdermal drug applicators

Also Published As

Publication number Publication date
WO1991015258A1 (en) 1991-10-17
NO923769D0 (no) 1992-09-28
DE69105202T2 (de) 1995-03-23
NO923769L (no) 1992-11-30
JPH05505964A (ja) 1993-09-02
DE69105202D1 (de) 1994-12-22
AU638581B2 (en) 1993-07-01
CA2079316A1 (en) 1991-10-01
NO308025B1 (no) 2000-07-10
FI924352A0 (fi) 1992-09-28
KR0169084B1 (ko) 1999-01-15
CA2079316C (en) 2002-01-01
DK0522092T3 (da) 1995-03-13
FI110066B (fi) 2002-11-29
GR3015116T3 (en) 1995-05-31
EP0522092A1 (en) 1993-01-13
KR930700181A (ko) 1993-03-13
FI924352A (fi) 1992-09-28
JP3181289B2 (ja) 2001-07-03
ATE114118T1 (de) 1994-12-15
EP0522092B1 (en) 1994-11-17
AU7991591A (en) 1991-10-30
US5207752A (en) 1993-05-04

Similar Documents

Publication Publication Date Title
ES2067939T3 (es) Sistema de distribucion de un medicamento iontoforetico con un perfil de reparto de dos etapas.
ATE234602T1 (de) Verabreichungsform zur abgabe von steigenden wirkstoffdosen
NO306377B1 (no) Doseform for avgivelse av et medikament
ES2176197T3 (es) Sistema de administracion transdermal que contiene un acido acetilsalicilico para la terapia de trombosis y la profilaxis del cancer.
IT1261849B (it) Dispositivo medico per la somministrazione di principi attivi o farmaci a bassissimo dosaggio, in particolare di farmaci omeopatici.
GT199900151A (es) Sistema de entrega controlado de droga administrado oralmente, que provee control temporal y espacial.
FR2622798B1 (fr) Forme d'apport dose et dispositif osmotique d'administration d'un medicament pour le traitement de maladies cardio-vasculaires
GEP20043216B (en) Orally Administered Controlled Drug Delivery System
PL287844A1 (en) Method of obtaining an oraly administered composite medicine for treating interstinal inflamatory diseases
DE69735848D1 (de) Dosisform mit ansteigender dosisfreisetzung
BR9802537A (pt) Método para anestesiar um paciente humano antes de cirurgias de porte dose unitária e sistema farmacêutico para administração
KR870700373A (ko) 동전학적 의약투여 속도를 제어하는 시스텝 및 방법
ES2043744T3 (es) Sistema de suministro transdermico de procaterol.
EP0429522A4 (en) Phosphosugar-based anti-inflammatory and/or immunosuppressive drugs
NO953003L (no) Anvendelse av ifenprodil og diastereoisomerer derav for fremstilling av medisinske preparater
ATE116845T1 (de) Dosierungsform zur verabreichung von arzneimitteln für die zirkadiantherapie.
RU2000110676A (ru) Способ консервативного лечения стриктур уретры
RU97101420A (ru) Способ лечения тонзиллита
RU98103823A (ru) Способ изменения свертывающей и противосвертывающей систем организма
RO96782A2 (ro) Medicament pentru tratarea enurezisului nocturn nevrotic
RU94022334A (ru) Способ лечения и профилактики инвазионных заболеваний
EA200000514A1 (ru) Способ лечения эректильной дисфункции
RU94037731A (ru) Способ лечения рассеянного склероза
UA10053A (uk) Спосіб лікування невиношування вагітності

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 522092

Country of ref document: ES